PARP1 and colitis: Inhibition of the nuclear enzyme PARP-1 may reduce the apoptotic process by shifting the ratio of apoptotic regulators along with reduction of JNK activity, and beneficial effects of inhibitors of this nuclear polymerase have been reported in experimental models of colitis [12], [28].